Bristol Myers Squibb discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products globally. The company's primary revenue streams are derived from sales of its products, primarily in the therapeutic classes of hematology, oncology, cardiovascular, and immunology. Bristol Myers Squibb is a leading biopharmaceutical company with a strong market position and competitive advantages in several key markets, including the U.S., EU, and Japan.